Enterprise Value to EBITDA Multiple ratio Analysis of INmune Bio Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-6.17
Period Ending - Dec-22
Very Poor EV to EBITDA
-5.76
Growth
-7.20 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Good EV to EBITDA
9.88
EV to EBITDA Analysis of INmune Bio Inc
| EV to EBITDA Ratio of INMB has fallen by -7.20 % Compared to previous Financial Year. |
| EV to EBITDA Ratio with value of -4.22 was highest in Year Dec-21 in last Five Years. |
| EV to EBITDA Ratio with value of -13.61 was lowest in Year Dec-19 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -6.17 is Greater than Average EV to EBITDA of -7.74 in last five years. |
Other EV to EBITDA Related Info of INMB that may interest you.
INmune Bio Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| INMB | 10.85 | 11.17 | 2.86 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of INmune Bio Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -6.17 | -5.76 | -4.22 | -8.94 | -13.61 | -9.77 | -144.75 |
| Change | -7.20 % | -36.56 % | 52.84 % | 34.31 % | -39.26 % | 93.25 % | 67.06 % |
FY Chart of Enterprise Value to EBITDA Multiple of INmune Bio Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)